{
  "$schema": "https://themachinepress.com/schemas/story-v1.schema.json",
  "schema_version": "1.0.0",
  "document_type": "machine_press_story",
  "story": {
    "story_id": "mp-2026-07-31-014",
    "source_story_id": "tmp-story-veteran-ptsd-psilocybin-pilot",
    "edition_id": "mp-2026-07-31-morning-0022",
    "edition_url": "https://themachinepress.com/edition/2026-07-31",
    "position": 14,
    "story_type": "dispatch",
    "section": "research",
    "editorial_classification": "editorial",
    "headline": "A Twelve-Veteran Trial Tested Psilocybin for PTSD",
    "slug": "a-twelve-veteran-trial-tested-psilocybin-for-ptsd",
    "dek": "The first U.S. pilot in severe treatment-resistant military PTSD reported no serious adverse events and substantial short-term remission.",
    "summary": "The first U.S. pilot in severe treatment-resistant military PTSD reported no serious adverse events and substantial short-term remission.",
    "body_text": "Ohio State researchers enrolled 12 veterans with severe, treatment-resistant PTSD in a psilocybin-assisted therapy pilot. The team reported no serious adverse events or increase in suicidality, and nine participants met remission criteria one month after treatment. With no control group and a very small sample, the study establishes feasibility and a signal for larger trials, not treatment efficacy for the broader veteran population.",
    "why_it_matters": "The first U.S. pilot in severe treatment-resistant military PTSD reported no serious adverse events and substantial short-term remission.",
    "limitations": [
      "With no control group and a very small sample, the study establishes feasibility and a signal for larger trials, not treatment efficacy for the broader veteran population."
    ],
    "importance": 8,
    "canonical_url": "https://themachinepress.com/story/mp-2026-07-31-014/a-twelve-veteran-trial-tested-psilocybin-for-ptsd",
    "json_url": "https://themachinepress.com/story/mp-2026-07-31-014.json",
    "first_published_at": "2026-07-31T09:00:00.000-04:00",
    "modified_at": "2026-07-31T09:00:00.000-04:00",
    "content_status": "new",
    "is_carryover": false,
    "carryover_reason": null,
    "key_claims": [
      {
        "claim_id": "claim-mp-2026-07-31-014-001",
        "text": "The first U.S. pilot in severe treatment-resistant military PTSD reported no serious adverse events and substantial short-term remission.",
        "source_ids": [
          "source-2026-07-31-014"
        ],
        "qualification": "With no control group and a very small sample, the study establishes feasibility and a signal for larger trials, not treatment efficacy for the broader veteran population."
      }
    ],
    "source_ids": [
      "source-2026-07-31-014"
    ],
    "tags": [
      "PTSD",
      "veterans",
      "psilocybin",
      "pilot trial"
    ],
    "image_url": null,
    "corrections": []
  },
  "sources": [
    {
      "source_id": "source-2026-07-31-014",
      "title": "Ohio State University via Newswise: Psilocybin-assisted therapy pilot for veterans with PTSD",
      "publisher": "The Ohio State University",
      "url": "https://www.newswise.com/articles/for-veterans-with-severe-ptsd-psilocybin-assisted-therapy-may-help",
      "canonical_url": "https://www.newswise.com/articles/for-veterans-with-severe-ptsd-psilocybin-assisted-therapy-may-help",
      "source_type": "official_announcement",
      "is_primary_source": true,
      "published_at": null,
      "accessed_at": "2026-07-31T08:31:33.328-04:00",
      "supports_claim_ids": [
        "claim-mp-2026-07-31-014-001"
      ]
    }
  ],
  "corrections": [],
  "publisher": {
    "name": "The Machine Press",
    "url": "https://themachinepress.com",
    "description": "A daily newspaper for the age of artificial intelligence."
  },
  "cite_this_report": {
    "title": "A Twelve-Veteran Trial Tested Psilocybin for PTSD",
    "publisher": "The Machine Press",
    "published_at": "2026-07-31T09:00:00.000-04:00",
    "canonical_url": "https://themachinepress.com/story/mp-2026-07-31-014/a-twelve-veteran-trial-tested-psilocybin-for-ptsd"
  }
}